Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification - PubMed (original) (raw)

Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification

Martha Savaria Morris et al. Am J Clin Nutr. 2007 Jan.

Abstract

Background: Historic reports on the treatment of pernicious anemia with folic acid suggest that high-level folic acid fortification delays the diagnosis of or exacerbates the effects of vitamin B-12 deficiency, which affects many seniors. This idea is controversial, however, because observational data are few and inconclusive. Furthermore, experimental investigation is unethical.

Objective: We examined the relations between serum folate and vitamin B-12 status relative to anemia, macrocytosis, and cognitive impairment (ie, Digit Symbol-Coding score < 34) in senior participants in the 1999-2002 US National Health and Nutrition Examination Survey.

Design: The subjects had normal serum creatinine concentrations and reported no history of stroke, alcoholism, recent anemia therapy, or diseases of the liver, thyroid, or coronary arteries (n = 1459). We defined low vitamin B-12 status as a serum vitamin B-12 concentration < 148 pmol/L or a serum methylmalonic acid concentration > 210 nmol/L-the maximum of the reference range for serum vitamin B-12-replete participants with normal creatinine.

Results: After control for demographic characteristics, cancer, smoking, alcohol intake, serum ferritin, and serum creatinine, low versus normal vitamin B-12 status was associated with anemia [odds ratio (OR): 2.7; 95% CI: 1.7, 4.2], macrocytosis (OR: 1.8; 95% CI: 1.01, 3.3), and cognitive impairment (OR: 2.5; 95% CI: 1.6, 3.8). In the group with a low vitamin B-12 status, serum folate > 59 nmol/L (80th percentile), as opposed to < or = 59 nmol/L, was associated with anemia (OR: 3.1; 95% CI: 1.5, 6.6) and cognitive impairment (OR: 2.6; 95% CI: 1.1, 6.1). In the normal vitamin B-12 group, ORs relating high versus normal serum folate to these outcomes were < 1.0 (P(interaction) < 0.05), but significantly < 1.0 only for cognitive impairment (0.4; 95% CI: 0.2, 0.9).

Conclusion: In seniors with low vitamin B-12 status, high serum folate was associated with anemia and cognitive impairment. When vitamin B-12 status was normal, however, high serum folate was associated with protection against cognitive impairment.

PubMed Disclaimer

Figures

FIGURE 1

Association between serum vitamin B-12 and serum folate in senior participants in the National Health and Nutrition Examination Survey (1999–2002) who had no evidence of renal dysfunction or history of stroke, alcoholism, recent anemia therapy, or diseases of the liver, thyroid, or coronary arteries (n = 1457). Points represent least-squares geometric means adjusted for age, sex, race-ethnicity, education, cancer, smoking, alcohol intake, and serum concentrations of ferritin and creatinine for supplement users and nonusers combined. Error bars represent 95% CIs. Quartile categories 1, 2, 3, and 4 are <271, 271–366, 367–484, and >484 pmol/L for supplement users and <208, 208–281, 282–350, and >350 pmol/L for nonusers, respectively. The direct association between serum vitamin B-12 and serum folate (_P_trend < 0.001) did not vary with supplement use (_P_interaction < 0.751).

Comment in

Folic acid fortification: the good, the bad, and the puzzle of vitamin B-12.
Smith AD. Smith AD. Am J Clin Nutr. 2007 Jan;85(1):3-5. doi: 10.1093/ajcn/85.1.3. Am J Clin Nutr. 2007. PMID: 17209170 No abstract available.
Cognitive impairment in older Americans in the age of folic acid fortification.
Berry RJ, Carter HK, Yang Q. Berry RJ, et al. Am J Clin Nutr. 2007 Jul;86(1):265-7; author reply 267-9. doi: 10.1093/ajcn/86.1.265. Am J Clin Nutr. 2007. PMID: 17616791 No abstract available.

Cited by

Exploring the Impact of Folic Acid Supplementation and Vitamin B12 Deficiency on Maternal and Fetal Outcomes in Pregnant Women with Celiac Disease.
Lev L, Petersen K, Roberts JL, Kupferer K, Werder S. Lev L, et al. Nutrients. 2024 Sep 21;16(18):3194. doi: 10.3390/nu16183194. Nutrients. 2024. PMID: 39339794 Free PMC article. Review.
Folate in the United States Population and its Association with Congestive Heart Failure.
Wang L, Yu F, Shi J, Ye T, Zhou Y, Sun Z, Yang J, Wang X. Wang L, et al. Rev Cardiovasc Med. 2024 Jan 29;25(2):39. doi: 10.31083/j.rcm2502039. eCollection 2024 Feb. Rev Cardiovasc Med. 2024. PMID: 39077347 Free PMC article.
Excess Folic Acid and Vitamin B12 Deficiency: Clinical Implications?
Miller JW, Smith A, Troen AM, Mason JB, Jacques PF, Selhub J. Miller JW, et al. Food Nutr Bull. 2024 Jun;45(1_suppl):S67-S72. doi: 10.1177/03795721241229503. Food Nutr Bull. 2024. PMID: 38987872 Free PMC article. Review.

References

1. US Food and Drug Administration, Health and Human Services. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid (final rule–21 CFR Part 101) Fed Reg. 1996;61:8781–97.
1. Rush D. Periconceptional folate and neural tube defect. Am J Clin Nutr. 1994;59(suppl):511S–5S. discussion 515S–6S. - PubMed
1. Herbert V, Bigaouette J. Call for endorsement of a petition to the Food and Drug Administration to always add vitamin B-12 to any folate fortification or supplement. Am J Clin Nutr. 1997;65:572–3. - PubMed
1. Herbert V. Vitamin B12. In: Ziegler EE, Filer LJ, editors. Present knowledge in nutrition. 7. Washington, DC: International Life Sciences Institute Press; 1996. pp. 191–205.
1. Rothenberg SP. Increasing the dietary intake of folate: pros and cons. Semin Hematol. 1999;36:65–74. - PubMed

Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification - PubMed (original) (raw)